Abeona Therapeutics (ABEO) Total Current Liabilities (2010 - 2026)

Abeona Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $31.0 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 72.64% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $31.0 million (up 72.64% YoY), while the FY2025 annual figure was $29.6 million, up 78.27% from the prior year.
• Total Current Liabilities was $31.0 million for Q1 2026 at Abeona Therapeutics, up from $29.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $34.5 million in Q2 2025 to a low of $7.4 million in Q1 2023.
• Historically, Total Current Liabilities has averaged $16.7 million across 5 years, with a median of $13.7 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities slumped 69.79% in 2022, then jumped 119.0% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $7.8 million in 2022, then jumped by 72.54% to $13.4 million in 2023, then increased by 23.58% to $16.6 million in 2024, then surged by 78.27% to $29.6 million in 2025, then grew by 4.99% to $31.0 million in 2026.
• The last three Total Current Liabilities figures came in at $31.0 million (Q1 2026), $29.6 million (Q4 2025), and $22.2 million (Q3 2025), per Business Quant data.